ChromoTek, Bayer sign license agreement for high content drug profiling
According to the agreement, Bayer will apply Chromobody technology for real time monitoring of cell cycle progression in drug discovery. The Chromobody Technology, a patented, universal live cell
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.